|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 10.68 USD | -2.47% |
|
0.00% | -41.45% |
| 08-05 | ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025. | CI |
| Market Cap | 2.39B 2.14B 1.97B 1.79B 3.35B 227B 3.4B 23.75B 9.4B 119B 8.98B 8.79B 375B | P/E 2026 * |
13.1x | P/E 2027 * | 11.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.39B 2.14B 1.97B 1.79B 3.35B 227B 3.4B 23.75B 9.4B 119B 8.98B 8.79B 375B | EV / Sales 2026 * |
4.47x | EV / Sales 2027 * | 3.8x |
| Free-Float |
90.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADMA | Delayed | |
CBOE
| ADMA | Real-time |
Last Transcript: ADMA Biologics, Inc.
| 22-12-07 | Wall Street lager gesloten | |
| 22-12-07 | Wall Street koerst af op vlak slot | |
| 22-12-07 | Wall Street verder omlaag bij opening | |
| 22-12-07 | Futures Wall Street wijzen omlaag | |
| 17-03-30 | Chinesischer Investor hat Interesse an Biotest |
| 1 day | -2.47% | ||
| Current month | +6.48% | ||
| 1 month | +10.10% | ||
| 3 months | +27.60% | ||
| 6 months | -3.61% | ||
| Current year | -41.45% |
| 1 week | 10.57 |  | 11.32 |
| 1 month | 9.23 | | 11.32 |
| Current year | 7.21 | | 18.95 |
| 1 year | 7.21 | | 20.46 |
| 3 years | 3.12 | | 25.67 |
| 5 years | 1.17 | | 25.67 |
| 10 years | 1.01 | | 25.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 49 | 2011-09-30 |
Paul Kohler
DFI | Director of Finance/CFO | 49 | 2026-02-25 |
| Compliance Officer | 39 | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jerrold Grossman
BRD | Director/Board Member | 78 | 2006-12-31 |
Steven Elms
CHM | Chairman | 62 | 2012-03-29 |
Adam Grossman
BRD | Director/Board Member | 49 | 2006-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 | Tax | Compliance Officer | -3,177 | 0.0014% | ||
| 7/16/26 | Free | Chief Financial Officer | 221,493 | 0.0956% | ||
| 5/27/26 | Buy | Founder | 6,400 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.47% | 0.00% | -29.97% | +246.75% | 2.39B | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,135B | |
| -1.42% | +3.23% | +37.07% | +74.26% | 636B | |
| +0.16% | +0.08% | +25.14% | +97.36% | 505B | |
| -0.31% | +3.09% | +43.92% | +64.55% | 378B | |
| -1.34% | -0.47% | +66.63% | +40.56% | 358B | |
| -0.68% | +2.65% | +22.46% | +51.48% | 295B | |
| -1.20% | +3.04% | +2.62% | +26.97% | 266B | |
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | |
| -0.73% | -0.10% | +29.24% | +101.19% | 193B | |
| Average | -0.85% | +1.95% | +30.22% | +88.48% | 400.67B | |
| Weighted average by Cap. | -0.26% | +2.66% | +40.95% | +82.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 535M 478M 442M 400M 749M 50.82B 761M 5.31B 2.1B 26.63B 2.01B 1.97B 83.95B | 630M 562M 519M 471M 881M 59.76B 895M 6.25B 2.47B 31.31B 2.36B 2.31B 98.72B |
| Net income | 191M 171M 158M 143M 268M 18.16B 272M 1.9B 752M 9.51B 718M 703M 30B | 223M 199M 184M 166M 311M 21.14B 317M 2.21B 875M 11.08B 836M 818M 34.92B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$10.68 | -2.47% | 1,740,919 |
| 26-10-22 | US$10.95 | -0.54% | 3,551,548 |
| 26-10-21 | US$11.01 | -1.96% | 2,006,446 |
| 26-10-20 | US$11.23 | +1.45% | 2,896,500 |
| 26-10-19 | US$11.07 | +3.65% | 2,873,908 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADMA Stock
Select your edition
All financial news and data tailored to specific country editions
